Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
ThioTEPA
CHF 37.45
Auf Lager
SKU
DPV4BD648DC
1 Verfügbar 
Geliefert zwischen Mo., 19.01.2026 und Di., 20.01.2026
Details
High Quality Content by WIKIPEDIA articles! It is mostly used to treat breast cancer, ovarian cancer, and bladder cancer. It is also used as conditioning for bone marrow transplantation. During surgery for ovarian cancer peritoneal washings should be done to remove any cancer cells. Microscopic examination of the fluid may indicate if tumour has spread to the peritoneum. Thiotepa may be left in the peritoneum to work as a chemotherapeutic agent.Thiotepa has been used in combinations with cyclophosphamide and carboplatin. Its main toxicity is myelosuppression.The most serious complication of excessive therapy is bone marrow depression, causing leukopenia, thrombocytopenia, and anemia. If WBC count falls to 3,000/mm 3 or less, discontinue use. If the platelet count falls to 150,000/mm 3 , discontinue therapy. In 2006 the National Cancer Institute recommended giving cisplastin and paclitaxel by both the intravenous and intraperitoneal route after ovarian cancer surgery.
Weitere Informationen
- Allgemeine Informationen
- GTIN 09786131053719
- Editor Lambert M. Surhone, Miriam T. Timpledon, Susan F. Marseken
- Genre Chemie
- EAN 9786131053719
- Format Fachbuch
- Titel ThioTEPA
- Herausgeber Betascript Publishing
- Anzahl Seiten 64
Bewertungen
Schreiben Sie eine Bewertung
